Document is current

Any future updates will be listed below

Discovery of 5-imidazole-3-methylbenz[d]isoxazole derivatives as potent and selective CBP/p300 bromodomain inhibitors for the treatment of acute myeloid leukemia

Crossref DOI link: https://doi.org/10.1038/s41401-025-01478-x

Published Online: 2025-01-31

Published Print: 2025-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark